The effect of Losartan, an angiotensin II antagonist, on cardiac function, mass and morphology in rats after repeated hyperbaric exposures

References

• Doubt T J, Hogan P M. Action potential correlates of pressure-induced changes in cardiac conduction. J Appl Physiol 1979; 47: 1169–75
   PubMed Web of Science ®Google Scholar
• Örnhagen H CH, Sigursson S B. Effect of high ambient pressure and oxygen tension on organ blood flow in the anesthetized rat. Undersea Biomed Res 1980; 7: 47–60
   PubMedGoogle Scholar
• Ask J, Tyssebotn I. Positive inotropic effect on the rat atrial myocardium compressed to 5,10 and 30 bar. Acta Physiol Scand 1988; 134: 277–83
   PubMedGoogle Scholar
• Bergø G W, Tyssebotn I. Increased breathing gas density enhances cardiac workload. Scand J Clin Lab Invest 1992; 52: 151–8
   PubMed Web of Science ®Google Scholar
• Stuhr L EB, Ask J A, Tyssebotn I. Effect of hyper-baric oxygen exposure (5 bar) on the cardiac contractility of anesthetized rats. Undersea Biomed Res 1988; 15: 30, Suppl
   Google Scholar
• Stuhr L EB, Ask J A, Tyssebotn I. Increased cardiac contractility in rats exposed to 5 bar. Acta Physiol Scand 1989; 136: 167–76
   PubMedGoogle Scholar
• Doubt T J, Evans D E. Hyperbaric exposures alter cardiac excitation-contraction coupling. Undersea Biomed Res 1982; 9: 131–45
   PubMedGoogle Scholar
• Onarheim J, Tyssebotn I. Effect of high ambient pressure and oxygen tension on organ blood flow in the anesthetized rat. Undersea Biomed Res 1980; 7: 47–60
   PubMedGoogle Scholar
• Hordnes C, Tyssebotn I. Effect of high ambient pressure and oxygen tension on organ blood flow in conscious trained rats. Undersea Biomed Res 1985; 12: 115–28
   PubMedGoogle Scholar
• Risberg J, Tyssebotn I. Hyperbaric exposure to a 5 ATA He-N2-O2 atmosphere affects the cardiac function and organ blood flow distribution in awake trained rats. Undersea Biomed Res 1986; 13: 77–90
   PubMedGoogle Scholar
• Risberg J, Bergø G W, Hordnes C, Tyssebotn I. Distribution of cardiac output in awake rats during exposure to 5 bar. Undersea Biomed Res 1990; 17: 503–14
   PubMedGoogle Scholar
• Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986; 58: 26–37
   PubMed Web of Science ®Google Scholar
• Carabello B A, Nakano K, Corin W, Biederman R, Spann J F, Jr. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol 1989; 256: H974–H981, (Heart Circ Physiol 25)
   Google Scholar
• Mahle B O, Giertsen J C, Tyssebotn I. Hypertrophy of the left cardiac ventricle in professional divers. J Hyperbaric Med 1989; 89: 189–95
   Google Scholar
• Stuhr L EB, Bergø G W, Skei S, Mahle B O, Tyssebotn I. Repeated normoxic hyperbaric exposures induce haemodynamic and myocardial changes in rats. Eur J Appl Physiol 1993; 66: 226–34
   Web of Science ®Google Scholar
• Waldenström A. The renin-angiotensin-adosterone system, and its inhibition in cardiac hypertrophy and insufficiency. Research in cardiac hypertrophy and failure, B Schyn-Ghedauw. INSERM/John Libbey Eurotext. 1990; 605–17
   Google Scholar
• Raya T E, Fonken S J, Lee R W, Dauherty S, Goldman S. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 1991; 4: 334S–349S, Suppl
   PubMed Web of Science ®Google Scholar
• Dahlöf B. The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy. J Hypertens 1993; 11: 29S–35S
   Web of Science ®Google Scholar
• Scoemaker R G, Debets J JM, Smits J FM. Effects of captopril on cardiac function in heart failure cannot be explained by angiotensin II-l receptor mediated mechanisms. FASEB J 1991; 5: 841
   Web of Science ®Google Scholar
• Brunner H R, Nussberger J, Warber B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the reninangiotensin system. J Hypertens 1993; 11: 53S–61S
   Web of Science ®Google Scholar
• Oddie C J, Dilley R J, Konellakis P, Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. H Hypertrens 1993; 11: 717–24
   PubMed Web of Science ®Google Scholar
• Aanderud L, Onarheim J, Tyssebotn I. Effect of 71 ATA He-O2 on organ blood flow in the rat. J Appl Physiol 1985; 2259: 1369–75
   Google Scholar
• Shiraki K, Sagawa S, Konda N, Nakayama H, Matsuda M. Hyperbaric diuresis at a thermone-utral 31 ATA He-O2 environment. Undersea Biomed Res 1984; 11: 4341–53
   Google Scholar
• Schunkert H, Sadoshima J-I, Cornelius T, Kagaya Y, Weinberg E O, Izumo S, Riegger G, Lorell B H. Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995; 76: 489–97
   PubMed Web of Science ®Google Scholar
• Morgan H E, Baker K M. Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation 1991; 83: 13–25
   PubMed Web of Science ®Google Scholar
• Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy?. J Hypertension 1991; 9: 3–15
   PubMed Web of Science ®Google Scholar
• Baker K M, Dostale D E, Chernin M I, Wealand A L, Conrad K M. Angiotensin II-mediated cardiac hypertrophy in adult rats. J Cell Biochem 1991, Suppl 15: 167
   PubMed Web of Science ®Google Scholar
• Dahlöf B. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. Drugs 1988; 35: 6–26
   PubMed Web of Science ®Google Scholar
• Campbell-Boswell M, Robertson A L, Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Molec Pathol 1981; 35: 265–76
   PubMed Web of Science ®Google Scholar
• Geisterfer A AT, Owens G K. Hypertrophic response of culured vascular smooth muscle cells to angiotensin II. Fed Proc 1986; 45: 584
   Google Scholar
• Mizuno K, Tani M, Hashimoto S, Niimura S, Sanada H, Watanabe H, Othsuki M, Fukkuchi S. Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Sci 1992; 5: 367–74
   Google Scholar
• Bruckschlegel G, Holmer S R, Jandeliet K, Grimm D, Muders F, Kromer E, Rigger G AJ, Schunkert H. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995; 25: 250–9
   PubMed Web of Science ®Google Scholar
• Devereux R B, Pickering T G, Cody R J, Laragh J H. Relation of renin-angiotensin system activity to the left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens 1987; 3: 87–103
   PubMed Web of Science ®Google Scholar
• Re R N. The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues. J Molec Cell Cardiol 1989; 21: 63–9, Suppl
   PubMed Web of Science ®Google Scholar
• Catron P W, Thomas L B, McDermott J J, Smallridge R C, Lake C R, Kinzer C, Chernav B, Flynn E T. Hormonal changes during decompression sickness. Undersea Biomed Res 1987; 14: 331–41
   PubMedGoogle Scholar
• Claysbaugh J R, Hong S K, Matsudi N, Nakayama H, Park Y S, Matsuda M. Responses of salt- and water-regulating hormones during a saturation dive to 31 ATA. Undersea Biomed Res 1984; 11: 65–80
   PubMedGoogle Scholar
• Smith R D, Chiu A T, Wong P C, Herblin W F, Timmermans P BMWM. Pharmacology of nonpeptide angiotensin II receptor antagonists. A Rev Pharmacol Toxicol 1992; 32: 135–65
   PubMed Web of Science ®Google Scholar
• Stuhr L EB, Ask J A, Tyssebotn I. Cardiovascular changes in anesthetized rats during exposure to 30 bar. Undersea Biomed Res 1990; 17: 383–93
   PubMedGoogle Scholar
• Ask J, Tyssebotn I. Positive inotropic effect on human atrial myocardium exposed to 30 bar. Undersea Biomed Res 1991; 18: 138
   Google Scholar